Jeremy A. O’Sullivan

845 citations
30 papers · 616 indexed · h-index 15

Jeremy A. O’Sullivan

30 papers receiving 610 citations

Peers

Jeremy A. O’Sullivan
Comparison fields: 5 of 71
  • Immunology 426
  • Immunology and Allergy 85
  • Rheumatology 115
  • Physiology 150
  • Oncology 90
Replace Hitomi Hoshino with:
Hitomi Hoshino Japan
Hui-Qing Xiao United States
Melinda Erdös Hungary
Renate Höchstetter Germany
Karen R. McLachlan United States
Tihomir Dodev United Kingdom
Urs Wirthmueller Switzerland
Holger Ruchatz United Kingdom
Stephen U. Stechschulte United States
Sandra Bajaña United States
Jeremy A. O’Sullivan relative to Hitomi Hoshino Japan Hitomi Hoshino's profile →
Citations per field
00.5×4.1×
Hitomi Hoshino · 1×
Citations per year

Countries citing papers authored by Jeremy A. O’Sullivan

Since Specialization
Citations

This map shows the geographic impact of Jeremy A. O’Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy A. O’Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy A. O’Sullivan more than expected).

Fields of papers citing papers by Jeremy A. O’Sullivan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy A. O’Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy A. O’Sullivan. The network helps show where Jeremy A. O’Sullivan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jeremy A. O’Sullivan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jeremy A. O’Sullivan Line = papers co-authored together Jeremy A. O’Sullivan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20236
2 20231
3 202312
4 20234
5 202225
6 202216
7 202062
8 20204
9 202053
10 202012
11 20191
12 201748
13 201784
14 201720
15 20161
16 201249
17 20127
18 20111
19 201118
20 201013

About Jeremy A. O’Sullivan

Jeremy A. O’Sullivan is a scholar working on Immunology, Rheumatology and Immunology and Allergy, having authored 30 papers that have together received 616 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (12 papers), Mast cells and histamine (10 papers), T-cell and B-cell Immunology (8 papers), Asthma and respiratory diseases (7 papers), Glycosylation and Glycoproteins Research (6 papers), Immunotherapy and Immune Responses (6 papers), Eosinophilic Disorders and Syndromes (6 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Immunology (426 citations), Immunology and Allergy (85 citations) and Rheumatology (115 citations). Jeremy A. O’Sullivan has collaborated with scholars based in United States, Croatia and Austria. Frequent co-authors include Bruce S. Bochner, Bradford A. Youngblood, Alan T. Chang, José A. Guevara-Patiño, Yun Cao, Frederick J. Kohlhapp, Andrew Zloza, Robert P. Schleimer, Tamson V. Moore and David B. Nix. Their work appears in journals such as Journal of the American Chemical Society, Nature Medicine and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026